ArticleClinical and experimental medicine2017
Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis.
Wan Yue-Meng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it